Log in

BATS:IBHAiShares iBonds 2021 Term High Yield and Income ETF Stock Price, Forecast & News

$23.75
+0.12 (+0.51 %)
(As of 06/4/2020 03:04 AM ET)
Add
Today's Range
$23.67
Now: $23.75
$23.75
50-Day Range
$23.05
MA: $23.32
$23.65
52-Week Range N/A
Volume3,200 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars


Basic Details

Issuer iShares
Fund NameiShares iBonds 2021 Term High Yield and Income ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:IBHA
Inception Date5/7/2019
Fund ManagerJames Mauro, Scott Radell
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
BenchmarkBloomberg Barclays 2021 Term High Yield and Income Index
CategoryCorporate
FocusBroad Debt
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$14.17 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker

Receive IBHA News and Ratings via Email

Sign-up to receive the latest news and ratings for IBHA and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of iShares iBonds 2021 Term High Yield and Income ETF (BATS:IBHA)
Currency Exposure of iShares iBonds 2021 Term High Yield and Income ETF (BATS:IBHA)
Sector Exposure of iShares iBonds 2021 Term High Yield and Income ETF (BATS:IBHA)
Industry Exposure of iShares iBonds 2021 Term High Yield and Income ETF (BATS:IBHA)

iShares iBonds 2021 Term High Yield and Income ETF (BATS:IBHA) Frequently Asked Questions

How has iShares iBonds 2021 Term High Yield and Income ETF's stock been impacted by COVID-19 (Coronavirus)?

iShares iBonds 2021 Term High Yield and Income ETF's stock was trading at $23.8520 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IBHA stock has decreased by 0.4% and is now trading at $23.75. View which stocks have been most impacted by Coronavirus.

Has iShares iBonds 2021 Term High Yield and Income ETF been receiving favorable news coverage?

News headlines about IBHA stock have been trending very negative on Thursday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. iShares iBonds 2021 Term High Yield and Income ETF earned a news impact score of -3.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutiShares iBonds 2021 Term High Yield and Income ETF.

What is iShares iBonds 2021 Term High Yield and Income ETF's stock symbol?

iShares iBonds 2021 Term High Yield and Income ETF trades on the BATS under the ticker symbol "IBHA."

How do I buy shares of iShares iBonds 2021 Term High Yield and Income ETF?

Shares of IBHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares iBonds 2021 Term High Yield and Income ETF's stock price today?

One share of IBHA stock can currently be purchased for approximately $23.75.

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.